Search research articles
Contact Us
Filters
Showing results (41-50 of 474) with videos related to
Page
of 48
Sort By:
World Journal of Urology
|
August 16, 2008
Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?
Hashim Uddin Ahmed, Mark Emberton
Current Opinion in Urology
|
October 2, 2015
Will the attributes of multiparametric MRI permit the creation of a new approach to therapy?
Caroline M Moore, Mark Emberton
BJU International
|
February 14, 2006
Dynamic variables: novel and perhaps better predictors of progression in benign prostatic hyperplasia
James N Armitage, Mark Emberton
The Lancet. Oncology
|
April 4, 2017
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer - Authors' reply
Abdel-Rahmène Azzouzi, Mark Emberton,
International Journal of Surgery (London, England)
|
April 28, 2007
Frequency volume charts should be used in men with lower urinary tract symptoms
Prasanna Sooriakumaran, Christian Brown, Mark Emberton
BJU International
|
September 22, 2009
High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up
Tim Dudderidge, Hashim Ahmed, Mark Emberton
BJU International
|
June 19, 2007
An algorithm for managing the failure of external beam radiotherapy in prostate cancer
Tim Dudderidge, Heather Payne, Mark Emberton
European Urology Focus
|
July 21, 2017
Repeat Prostate Biopsy: Rationale, Indications, and Strategies
Umberto Capitanio, David Pfister, Mark Emberton
Medical Image Analysis
|
July 19, 2016
From computer-assisted intervention research to clinical impact: The need for a holistic approach
Sébastien Ourselin, Mark Emberton, Tom Vercauteren
Archivos Espanoles De Urologia
|
March 12, 2019
New standards in prostate biopsy
José Marenco, Veeru Kasivisvanathan, Mark Emberton
Page
of 48
Search research articles
Search
Showing results (41-50 of 474) with videos related to
Sort By:
Page
of 48
World Journal of Urology
|
August 16, 2008
Active surveillance and radical therapy in prostate cancer: can focal therapy offer the middle way?
Hashim Uddin Ahmed, Mark Emberton
Current Opinion in Urology
|
October 2, 2015
Will the attributes of multiparametric MRI permit the creation of a new approach to therapy?
Caroline M Moore, Mark Emberton
BJU International
|
February 14, 2006
Dynamic variables: novel and perhaps better predictors of progression in benign prostatic hyperplasia
James N Armitage, Mark Emberton
The Lancet. Oncology
|
April 4, 2017
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer - Authors' reply
Abdel-Rahmène Azzouzi, Mark Emberton,
International Journal of Surgery (London, England)
|
April 28, 2007
Frequency volume charts should be used in men with lower urinary tract symptoms
Prasanna Sooriakumaran, Christian Brown, Mark Emberton
BJU International
|
September 22, 2009
High-intensity focused ultrasound for localized prostate cancer: initial experience with a 2-year follow-up
Tim Dudderidge, Hashim Ahmed, Mark Emberton
BJU International
|
June 19, 2007
An algorithm for managing the failure of external beam radiotherapy in prostate cancer
Tim Dudderidge, Heather Payne, Mark Emberton
European Urology Focus
|
July 21, 2017
Repeat Prostate Biopsy: Rationale, Indications, and Strategies
Umberto Capitanio, David Pfister, Mark Emberton
Medical Image Analysis
|
July 19, 2016
From computer-assisted intervention research to clinical impact: The need for a holistic approach
Sébastien Ourselin, Mark Emberton, Tom Vercauteren
Archivos Espanoles De Urologia
|
March 12, 2019
New standards in prostate biopsy
José Marenco, Veeru Kasivisvanathan, Mark Emberton
Page
of 48